You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-17. Route of administration of primary drug as main reason for asking treatment among new and all outpatient clients in 2005 [see all tables in this series...]

Part (iii) Percentage amongst new clients with stimulants (other than cocaine) as primary drug

Country		Inject	Smoke/inhale	Eat/drink	Sniff	Others	Base (known status)	Status unknown
Bulgaria		0.0	0.0	0.0	75.0	25.0	4	0
Czech Republic		64.3	1.2	3.1	31.3	0.0	482	5
Denmark		1.7	0.0	31.9	66.4	0.0	119	33
Germany		0.5	5.0	59.8	28.4	6.3	2339	2807
Ireland		0.0	0.0	91.6	8.4	0.0	95	1
Greece		0.0	0.0	100.0	0.0	0.0	2	0
Spain	(1)	0.2	3.5	51.0	43.0	2.2	453	11
France		0.0	6.3	85.4	8.3	0.0	48	2
Italy		0.0	4.0	93.8	2.2	0.0	321	0
Cyprus		0.0	0.0	66.7	33.3	0.0	3	0
Latvia		66.3	2.0	27.7	4.0	0.0	101	9
Lithuania		58.8	11.8	29.4	0.0	0.0	17	0
Hungary		4.7	0.5	80.5	13.7	0.5	591	0
Malta		0.0	0.0	100.0	0.0	0.0	4	1
Netherlands	(2)	0.5	7.6	36.5	52.8	2.5	394	42
Slovakia		26.2	28.7	5.7	36.9	2.5	122	3
Finland		70.7	0.9	10.3	18.1	0.0	116	2
Sweden		26.6	0.0	63.3	10.2	0.0	128	8
United Kingdom	(3)	12.6	3.6	73.9	6.4	3.6	1939	287
Total		11.3	4.1	59.1	22.1	3.4	7278	3211

Notes:

Only countries where there are clients reported with stimulants as primary drug are shown.

(1) Data refer to 2004.

(2) Data refer to outpatient treatment centres and low-threshold agencies.

(3) Data refer to collection period between 01.04.2004 and 31.03.2005.

See also 'Table TDI-110' for cocaine CIH and crack route of administration distribution, and 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - TDI - outpatient treatment centres.